News
Glaxosmithkline Pharmaceuticals consolidated net profit rises 12.44% in the June 2025 quarter
01-Aug-2025 | 12:53
Sales decline 1.16% to Rs 805.17 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 12.44% to Rs 205.01 crore in the quarter ended June 2025 as against Rs 182.33 crore during the previous quarter ended June 2024. Sales declined 1.16% to Rs 805.17 crore in the quarter ended June 2025 as against Rs 814.65 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended | ||
| Jun. 2025 | Jun. 2024 | % Var. | |
| Sales | 805.17 | 814.65 | -1 |
| OPM % | 31.20 | 28.30 | - |
| PBDT | 294.50 | 265.81 | 11 |
| PBT | 278.98 | 249.40 | 12 |
| NP | 205.01 | 182.33 | 12 |
Powered by Capital Market - Live News